Evidence map›Paper›PMID 36675020›Full record

ReviewInternational journal of molecular sciences2023

The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer.

Jolanta Smok-Kalwat, Paulina Mertowska, Sebastian Mertowski, Konrad Smolak, Aleksandra Kozińska, Filip Koszałka, Wojciech Kwaśniewski, Ewelina Grywalska, Stanisław Góźdź

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Expression and diagnostic value of serum free light chain in lung cancer.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Jolanta Smok-KalwatDepartment of Clinical Oncology, Holy Cross Cancer Centre, 3 Artwinskiego Street, 25-734 Kielce, Poland.
Paulina MertowskaDepartment of Experimental Immunology, Medical University of Lublin, 4a Chodzki Street, 20-093 Lublin, Poland.ORCID 0000-0001-9530-6659
Sebastian MertowskiDepartment of Experimental Immunology, Medical University of Lublin, 4a Chodzki Street, 20-093 Lublin, Poland.ORCID 0000-0002-7121-1396
Konrad SmolakDepartment of Experimental Immunology, Medical University of Lublin, 4a Chodzki Street, 20-093 Lublin, Poland.
Aleksandra KozińskaStudent Research Group of Experimental Immunology, Medical University of Lublin, 4a Chodzki Street, 20-093 Lublin, Poland.
Filip KoszałkaStudent Research Group of Experimental Immunology, Medical University of Lublin, 4a Chodzki Street, 20-093 Lublin, Poland.
Wojciech KwaśniewskiDepartment of Gynecologic Oncology and Gynecology, Medical University of Lublin, 20-081 Lublin, Poland.ORCID 0000-0002-7522-1401
Ewelina GrywalskaDepartment of Experimental Immunology, Medical University of Lublin, 4a Chodzki Street, 20-093 Lublin, Poland.ORCID 0000-0002-0451-4741
Stanisław GóźdźDepartment of Clinical Oncology, Holy Cross Cancer Centre, 3 Artwinskiego Street, 25-734 Kielce, Poland.
Medical University of Lublin · PLHoly Cross University · PLJan Kochanowski University · PL

Funding

Medical University of Lublin DS 640
6 · The paper itself

Abstract

Lung cancer is a disease that in recent years has become one of the greatest threats to modern society. Every year there are more and more new cases and the percentage of deaths caused by this type of cancer increases. Despite many studies, scientists are still looking for answers regarding the mechanisms of lung cancer development and progression, with particular emphasis on the role of the immune system. The aim of this literature review was to present the importance of disorders of the immune system and the accompanying changes at the level of cell signaling in the pathogenesis of lung cancer. The collected results showed that in the process of immunopathogenesis of almost all subtypes of lung cancer, changes in the tumor microenvironment, deregulation of immune checkpoints and abnormalities in cell signaling pathways are involved, which contribute to the multistage and multifaceted carcinogenesis of this type of cancer. We, therefore, suggest that in future studies, researchers should focus on a detailed analysis of tumor microenvironmental immune checkpoints, and to validate their validity, perform genetic polymorphism analyses in a wide range of patients and healthy individuals to determine the genetic susceptibility to lung cancer development. In addition, further research related to the analysis of the tumor microenvironment; immune system disorders, with a particular emphasis on immunological checkpoints and genetic differences may contribute to the development of new personalized therapies that improve the prognosis of patients.

Indexed as

Lung NeoplasmsCarcinogenesisHumansImmune SystemSignal TransductionTumor Microenvironmentgenetic associationimmune systemimmunopathogenesislung cancersignal transduction pathway

Identifiers

PMID36675020
PMCPMC9861992
OpenAlexW4315700918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.